INTRODUCTION
It is increasingly recognized that the modern diseases of childhood (e.g., autism, asthma, metabolic syndrome, attention deficit hyperactivity disorder, and so on), are not predictable by genetics, but instead arise because of complex interactions among early life environmental factors, that act independently, via mixtures or via modification by genetic susceptibility [1] [2] [3] . The true relational model of disease causation likely reflects interactions between genetic/epigenetic variation, environmental stressors, and the consequent endogenous biological responses that may modify or mediate effects of external exposures (Fig. 1) . The National Institutes of Health environmental influences on child health outcomes (ECHO) program emphasizes the need to (CHEAR) addresses such challenges by analyzing biological samples to understand environmental exposures and their timing more accurately and comprehensively [4, 5] . CHEAR emphasizes the consideration of mixtures of chemical, as well as nonchemical (social/behavioral/dietary/physical) stressors, to more fully understand health risks [6] [7] [8] . Environmental exposures affect multiple physiological processes and key regulatory systems simultaneously, particularly in sensitive periods of development, which shape health and development throughout life [9, 10] starting in utero.
Coordinated functioning of multiple networks of complex processes are necessary for optimal development and the maintenance of health. If one or more key regulatory systems are stressed by external environmental factors, plasticity -the ability of the organism to respond to an insult and still maintain homeostasis -can be overwhelmed, with consequent health impacts. Programming effects can result from shifts in a number of molecular, cellular, and physiological states and their interacting systems. Environmental exposures affect many overlapping homeostatic processes. As the field advances, our ability to integrate comprehensive assessment of environmental exposures with biological response biomarkers characterized by the evolving high-throughput 'omics' approaches will enable systematic analysis of exposure and response and the dynamic influences of the environment on health effects throughout the life course [11] .
In the last 30 years, significant advances have been made in understanding the influence of environmental factors on children's health, resulting in policies that have reduced environmental chemical exposure (e.g., removal of lead from gasoline). Nonetheless, there are more than 80 000 chemicals
KEY POINTS
Biomarkers can both inform environmental exposure and their biological effects.
Early life environmental exposures can predict health and development decades later.
Lab consortiums can reduce error and bias in biomarker research compared to ad hoc laboratory use. FIGURE 1. Organization of environmental measures and effects. Organization of environmental indicators. Known and unknown toxicants interact with nutrition and social stressors to elicit a biological response via multiple physiologic pathways. This response depends on the life stage at which exposure occurs. The targeted resource will provide validated markers of exposure to known toxicants, nutrients, and stress markers. The untargeted resource will undertake exposomic analyses to assess a wide range of unknown chemical signatures that include environmental chemicals, their breakdown products, and biomolecular signatures of disrupted cellular function. registered for industrial use by the Environmental Protection Agency (EPA) [12] , and for most of them, little to no research on their impact on child health has been performed. Just as genomic principles revolutionized the scope and pace of genetics, the CHEAR consortium is designed to quicken the pace of environmental health research and rapidly advance our understanding of the impact of the environmental chemicals, in all their complexity, on child development and physiology. However, many barriers remain to undertaking comprehensive environmental health studies in children. Here, we outline the major challenges facing exposure science and describe how the CHEAR program provides a resource that allows ECHO scientists to overcome these barriers.
First, children are exposed to mixtures of many chemicals, their metabolites, and stress responses in their daily lives; however, most epidemiologic studies examine single toxicants or small groups of compounds seldom taking on complex mixtures. A major barrier to undertaking mixtures research has been a lack of tools to comprehensively assess simultaneous exposure to a variety of environmental chemicals/exposures and the dearth of advanced statistical methods that can unravel the health effects of such chemical mixtures [9] . The CHEAR targeted analysis resources provide a comprehensive suite of analytical capabilities for quantifying metal and organic toxicants, nutritional compounds, and markers of social stressors that can be incorporated into existing child health studies.
The second major barrier to children's environmental health research is the sheer number of chemicals in the human environment. The concept of the 'exposome', that is, the totality of environmental exposures over the course of a lifetime, captures the scope of what CHEAR is about. Although hundreds of thousands of potential toxicants are present in our environment, only a small portion of them are being studied. It is not possible to keep pace with the rapid rate at which new chemicals are introduced unless we fundamentally change our approach and accept the role of data-driven science as a tool for chemical biomarker discovery [13-15,16 && ]. Datadriven research has led to an explosion of discoveries in genomics, epigenomics, proteomics, and metabolomics. Exposomics is the new 'omic' science to enable the hypothesis-free discovery of exposures associated with health-related endpoints and their subsequent replication in independent populations. The CHEAR untargeted analysis resource will discover and validate these currently unknown toxicants and their metabolic products.
The third major challenge to children's environmental health research is the lack of methods that can assess exposures which occur during sensitive periods or windows -that is, developmental stages when individuals have heightened vulnerability to specific environmental exposures [17] [18] [19] . In fetal life in particular, profound developmental changes occur on a time scale of days to weeks; consequently, single measures of environmental exposure in blood or urine designed to characterize exposure over a trimester or entire pregnancy will undoubtedly miss critical windows during which a sensitive biological process occurs. Methods that can capture repeated and/or integrated exposure over these time points would rapidly advance our understanding of how environment and developmental biology interact. Thus, the CHEAR lab network includes developmental cores to overcome these limitations by developing and validating methods for exposure analysis whether that is for emerging exposures (replacements for pesticides, flame, retardants, and so on), novel biological matrices (placenta, cerebral spinal fluid, and so on), or to enable retrospective exposure analysis (teeth, hair, nails). These approaches will provide more precise, unbiased, retrospective biomarkers of multichemical exposures at specific life stages, enabling a more comprehensive record of environmental exposures than is currently possible on a study of the magnitude of ECHO. These developmental cores, as well as cores in biological response assays (epigenetics, inflammation biomarkers and so on) are unique to CHEAR and outside the scope of the ECHO-CHEAR collaboration but can nonetheless be accessed by ECHO cohorts through partnerships with CHEAR labs. Figure 2 illustrates CHEAR's overall integration into ECHO with its primary role being integration of biomarkers into the larger ECHO program.
THE MISSION OF CHEAR
CHEAR is based on the concept of 'transdisciplinary exposure science.' The consortium integrates expertise from a number of disciplines (e.g., exposure science, analytical chemistry, pediatrics, toxicology, molecular biology and 'omics', epidemiology, biostatistics, bioinformatics, data science). Although CHEAR provides state-of-the-art analyses of targeted and untargeted biomarkers of exposure in many different matrices (Table 1) , it also develops and implements new exposure biomarkers that can measure thousands of chemical signatures simultaneously, or objectively determine the dose and timing of past exposures. Our broad expertise and support for collaborative consultation distinguishes CHEAR from other service oriented or commercial labs and illustrates the value of transdisciplinary approaches that bring together chemistry, pediatric development, and data analytics.
ENGAGEMENT WITH ECHO COHORTS
A major strength of CHEAR is the combination of interdisciplinary expertise and years of children's environmental health research experience that can be offered to ECHO [19, 20, [21] [22] [23] [24] . The integration of CHEAR into ECHO will facilitate well powered analyses of the impact of exposures to mixtures of environmental chemicals/agents/? in children. It would be naïve to think that fundamental principles of child development, exposure biology, and study design that will apply can be addressed post hoc. Thus, all cohorts serviced by our hubs undergo a rigorous presample analysis consultation process, to maximize the potential benefits of the exposure biomarkers to be assayed. This discussion is critical, as it combines the indepth knowledge of the ECHO cohort investigators on their populations and the outcome data available with CHEAR's expertise in child development, exposure science, analytical chemistry, and pediatric phenotyping. Simply adding an exposure biomarker to an existing cohort without considering these factors would reduce the effectiveness of the program and limit its ability to meet its goals. Cohort clients are active participants in this process. Although the client/Principal Investigator often have more expertise than CHEAR personnel in the scientific fields relevant to their Cohort's aims (psychology, asthma, obesity, and so on) s/he is likely to unfamiliar with all relevant issues in exposure analysis, analytical chemistry, toxicology, or environmental health. Collaboration is necessary to merge exposure science into ECHO and avoid pitfalls of a scientific, analytic, biologic nature as neither field can do this work alone. To provide expert counsel, it is incumbent upon CHEAR to comprehensively understand the client's study, its design, the types of biological specimens collected, their storage conditions, the participants' age at time of collection, and unusual characteristics.
TARGETED ANALYSIS
The hallmark of targeted analysis is the hypothesisdriven application of state-of-the-art biomonitoring for specific chemical analytes both endogenous and exogenous, known or suspected to affect or modify risk for health outcomes in children. CHEAR run analyses provide quantitative accuracy, sensitivity, and specificity because of rigorous quality control and the incorporation of standard benchmark materials which facilitate the direct comparison of analyses across studies. The CHEAR laboratory hubs focus is on three key categories of exposures: inorganic biomarkers, including metals (e.g., lead) metalloids (e.g., arsenic) and minerals (e.g., selenium); organic compounds, including plastic stabilizers, halogenated hydrocarbons, organic pesticides, tobacco smoke, and polycyclic aromatic hydrocarbons; and nutritional and social environment and stress biomarkers, including cortisol and lipid profiles in various media. We encourage a broad range of assays be run whenever feasible (barring sample type, condition, study design, or toxicologic concerns), to determine the potential interactions implicit in simultaneous exposure to multiple chemicals or the interactions among chemicals and social stressors or nutrition (or its deficit).
Although studies of environmental mixtures are complex, they represent the real-life scenario that children, pregnant women, and their families face daily.
UNTARGETED ANALYSIS
Most studies of toxic chemicals have used a reductionist, 'single chemical at a time' approach, but humans are not exposed to a single chemical at a time. Given the multifaceted nature of biologic interactions, it is difficult to conceive that one environmental exposure can ever primarily account for the complexity of the current 'morbidities of childhood.' In addition, there are certainly chemicals/ metabolites important to disease pathogenesis or child development whose existence is not yet known, and the 'single chemical at a time' approach might never comprehensively identify such chemicals. Because population studies take years to conduct and are expensive, methods that have the capacity to measure the exposome have the potential to allow the research community to more fully understand how chemicals and environment affect children's health.
To contextualize the scope of this issue, as mentioned earlier, more than 80 000 chemicals are registered with the EPA for commercial use in the United States [12] . If we are to tackle the challenge of understanding how our environment impacts health/disease, scholars are asserting that we must rethink how we conduct environmental health research [25, 26] . Just as genetics capitalized on the genome-wide scan to advance gene 'discoveries,' environmental health studies utilizing untargeted scans allow for screening of the exposome/metabolome (or subsets of it) to 'discover' novel environmental risk factors [15] and their effects [13] . Although we cannot measure the entirety of the exposome, we have demonstrated the potential of applying untargeted metabolomics technologies to discover possible unknown exposures associating with outcome signatures. Given access to the multiple populations within ECHO, CHEAR will have the opportunity to mirror genomic studies in which hypotheses are generated in one population and then test those hypotheses in separate populations, as a validation/replication method [27 & ,28] . Thus, CHEAR's untargeted resources provide a comprehensive unbiased approach to biomarker discovery by using exposomic technologies such as: metabolomics, which profiles the unique breakdown products of both exogenous and endogenous molecules; lipidomics, to profile the effects on the molecular building blocks of cells; and adductomics, to quantify modification of, or adducts to, biomolecules.
BENEFITS OF DEDICATED EXPOSURE ANALYSIS RESOURCES
Epidemiology studies commonly use core labs that use medium to high throughput validated assays, often through contracts with commercial vendors. Such labs differ in key ways from research laboratories that service only a single researcher, or handful of lab faculty. Perhaps more importantly, a consortium, such as ECHO will have special needs that even a core lab or commercial vendor cannot typically provide. For example, the sheer volume of samples is likely to overwhelm all but a handful of individual labs. Even if capacity exists, careful attention to batch effects, interinstrument/interlab variability is needed to reduce bias introduced by nonrandom measurement error. The STrengthening the Reporting of OBservational studies in Epidemiology -Molecular Epidemiology statement [28] outlines many of the critical special requirements for laboratories used for epidemiologic studies, all of which CHEAR follows. Of greatest importance is the need for careful consideration of biological sample processing and storage, and the validity/reliability of biomarker assays. The complexity of the CHEAR network mandates thoughtful consideration of laboratory information management and tracking such as the OpenSpecimen software system, and Open-LAB software. These integrated programs support cross-laboratory data and information management. Laboratory information management systems and sample tracking systems tailor the electronic management system specifically to the needs of both internal users and external stakeholders. CHEAR runs extensive Quality Assurance/Quality Control (QA/QC) procedures, including round robin studies in collaboration with all six lab hubs to determine the practical limits for detecting and quantifying each of the proposed analytes. These efforts address accuracy, precision and reproducibility, between labs as well as the within lab variability. CHEAR has a collection of pooled quality assurance specimens that will be included in all analyses supported by the consortium. These 'technical replicates' offer the ability to adjust results for both batch effects and interlaboratory variability. This is an important and unique feature that an ad hoc collection of labs could not offer. As additional standard reference materials become available from the national institute of standards and technology, CHEAR will validate its methods using national institute of standards and technologyrecommended concentrations for these analytes in the respective biological matrices. Finally, because we are a lab consortium, conducting QA/QC in tandem, this allows for unprecedented coordination of methods, development of common standards, and the ability to understand and adjust for too often unseen sources of bias.
CONCLUSION
ECHO represents a shift in focus from single exposure -disease inquiries to one that addresses multiple risk factors linked through shared vulnerabilities and shared biological networks. The life-course approach emphasizes the need to understand the chemical, biological, genetic, and social/behavioral factors that independently, cumulatively, and interactively influence health and development, starting prenatally and continuing through each life stage [8, 29] . CHEAR also emphasizes the analysis of mixtures of chemical as well as nonchemical (social, nutritional) stressors [6] [7] [8] . We developed statistical approaches to assess the combinability of existing studies with a variety of exposure-sampling protocols, covariate data, child health phenotypes, and archived biological samples. Given CHEAR's expertise and analytic capabilities, we can provide ECHO with intellectual and analytical resources needed to address the challenges of cohort harmonization for chemical exposure. Such work can inform the upstream early life environmental cause of complex chronic diseases of childhood (e.g., perinatal health, obesity, respiratory health, neurodevelopment), whereas setting the stage for large scale, big data genome by exposome interaction research.
